Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients

Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients

<h3>Background:</h3><p dir="ltr">There has been a significant improvement in both our understanding and therapeutic choices available to clinicians for the management of cancer associated thrombosis (CAT). Even with the recent publication of a systematic review and landma...

Full description

Saved in:
Bibliographic Details
Main Author: Mohammed ibn-Mas’ud Danjuma (20278119) (author)
Other Authors: Mouhand F.H. Mohamed (16932579) (author), Mohamad Nabil ElShafei (10223507) (author), Haajra Fatima (9376835) (author), Shaikha Al Shokri (18131404) (author), Sara Mohamed (5961536) (author), Ibrahim Yusuf Abubeker (20278122) (author), Anand Kartha (9658520) (author), Abdel-Naser Elzouki (9376853) (author), Mohamed Gaafar Hussein Mohamedali (16316289) (author), Yahya Mahgboub (20278125) (author), Mubarak Bidmos (20278128) (author)
Published: 2020
Subjects:
Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
cancer associated thrombosis
cancer thrombosis
DOAC
DVT
NOAC
novel oral anticoagulant
pulmonary embolism
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items